Filing Details
- Accession Number:
- 0001179110-14-012984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-18 16:09:55
- Reporting Period:
- 2014-08-15
- Filing Date:
- 2014-08-18
- Accepted Time:
- 2014-08-18 16:09:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145460 | Alere Inc. | ALR | In Vitro & In Vivo Diagnostic Substances (2835) | 043565120 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1383959 | Dave Teitel | 51 Sawyer Road, Suite 200 Waltham MA 02453 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-15 | 10,000 | $24.25 | 15,002 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-15 | 10,000 | $35.07 | 5,002 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-08-15 | 10,000 | $0.00 | 10,000 | $24.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-12-17 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form were made pursuant to a Rule 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1. Represents same day exercise and sale of expiring stock options.
- This price represents the average purchase price for 65 separate transactions reported on this line. The price of the transactions reported on this line range from $34.68 to $35.25. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.
- These options became exercisable in four equal annual installments beginning 12/17/2005.
- This derivative security does not have a price.
- Includes 206 shares acquired under the Alere Inc. Employee Stock Purchase Plan on June 30, 2014.
Billionaire Hedge Funds
